Legal & General Group
FLNA

Legal & General Group’s Filana Therapeutics FLNA Stock Holding History

Legal & General Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,256
Closed -$10.9K – 3523
2025
Q1 		$10.9K Sell
7,256
-39,112
-84% -$98.7K ﹤0.01% 3145
2024
Q4 		$109K Buy
46,368
+742
+2% +$13K ﹤0.01% 2716
2024
Q3 		$1.34M Sell
45,626
-2,928
-6% -$67.4K ﹤0.01% 2126
2024
Q2 		$600K Buy
48,554
+6,531
+16% +$138K ﹤0.01% 2355
2024
Q1 		$853K Buy
42,023
+1,209
+3% +$27.9K ﹤0.01% 2245
2023
Q4 		$919K Buy
40,814
+3,318
+9% +$70.1K ﹤0.01% 2241
2023
Q3 		$624K Buy
37,496
+66
+0.2% +$1.31K ﹤0.01% 2349
2023
Q2 		$918K Buy
37,430
+305
+0.8% +$7.34K ﹤0.01% 2259
2023
Q1 		$895K Buy
37,125
+2,537
+7% +$70.3K ﹤0.01% 2178
2022
Q4 		$1.02M Sell
34,588
-143
-0.4% -$5.14K ﹤0.01% 2151
2022
Q3 		$1.45M Buy
34,731
+365
+1% +$9.86K ﹤0.01% 2013
2022
Q2 		$966K Sell
34,366
-820
-2% -$20.7K ﹤0.01% 2174
2022
Q1 		$1.31M Buy
35,186
+1,239
+4% +$52.5K ﹤0.01% 2144
2021
Q4 		$1.48M Buy
33,947
+152
+0.4% +$7.97K ﹤0.01% 2135
2021
Q3 		$2.1M Buy
33,795
+24,849
+278% +$2.07M ﹤0.01% 2006
2021
Q2 		$765K Buy
8,946
+5,958
+199% +$319K ﹤0.01% 2259
2021
Q1 		$134K Sell
2,988
-76
-2% -$2.99K ﹤0.01% 2538
2020
Q4 		$21K Buy
3,064
+708
+30% +$6.32K ﹤0.01% 3073
2020
Q3 		$27K Sell
2,356
-902
-28% -$4.07K ﹤0.01% 2884
2020
Q2 		$10K Buy
+3,258
New +$14.8K ﹤0.01% 3311

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Legal & General Group's FLNA Position: Q2 2025 in Review

Legal & General Group sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 7,256 shares — an estimated $10.9K sold.

Legal & General Group first reported a position in FLNA in Q2 2020 and held it in 20 quarters. The position peaked at $2.1M in Q3 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Legal & General Group reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 7,256 Filana Therapeutics shares in Q2 2025, an estimated $10.9K.
  • Legal & General Group first reported a position in Filana Therapeutics in Q2 2020 and held it in 20 quarters.
  • Legal & General Group's Filana Therapeutics position peaked at $2.1M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.